1-3 of 3
Fiona Miall, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Polatuzumab Vedotin Plus Obinutuzumab and Lenalidomide in Patients With Relapsed/Refractory Follicular Lymphoma: Primary Analysis of the Full Efficacy Population in a Phase Ib/II Trial

Catherine Diefenbach, MD, Brad S. Kahl, MD, Lalita Banerjee, FRCPath, Andrew K McMillan, FRCP, Fiona Miall, MD FRCPath, MRCP, BMBS, Javier Briones, MD PhD, Raul Cordoba, MD PhD, Jamie Hirata, PharmD, YiMeng Chang, MSc, Lisa Musick, PharmD, Pau Abrisqueta, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 126.
https://doi.org/10.1182/blood-2019-123669
Published: 2019
Journal Articles

A Variety of T-Cell Subsets Contribute to CD4+ T-Cell Infiltration in Diffuse Large B-Cell Lymphoma and Both Total CD4+ and CD4+FoxP3+ T-Cell Numbers Predict Clinical Outcome,

Matthew J Ahearne, MBChB MRCP, Kaljit S Bhuller, MBChB MRCP, Roger Hew, MBChB, Giovanna Roncador, Martin J.S. Dyer, MA, DPhil, Daniel B. Kennedy, Fiona Miall, MD, Simon D. Wagner, MBBS, PhD, FRCP
Journal: Blood
Blood (2011) 118 (21): 3684.
https://doi.org/10.1182/blood.V118.21.3684.3684
Published: 2011
Journal Articles

An Intergroup Randomised Trial of Rituximab Versus a Watch and Wait Strategy In Patients with Stage II, III, IV, Asymptomatic, Non-Bulky Follicular Lymphoma (Grades 1, 2 and 3a). A Preliminary Analysis

Kirit M Ardeshna, MD, Wendi Qian, Paul Smith, June Warden, Lindsay Stevens, Christopher FE Pocock, MD, PhD, Fiona Miall, MD, David Cunningham, MD, John Davies, MD, Jan Walewski, A. Burhan Ferhanoglu, MD, Ken Bradstock, MB, PhD, David C Linch, MD, FMedSci
Journal: Blood
Blood (2010) 116 (21): 6.
https://doi.org/10.1182/blood.V116.21.6.6
Published: 2010